1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Adrenocortical Hyperfunction: new trials by email Literature Review of Adrenocortical Hyperfunction trials Research Report on Adrenocortical Hyperfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia NBI-77860 - Congenital Adrenal Hyperplasia | Phase 1 | Withdrawn | Neurocrine Biosciences | 2015-02-01 | 2015-06-11 |
Adrenal Gland Diseases (1) · Adrenal Hyperplasia, Congenital (1) · Adrenogenital Syndrome (1) · Congenital Abnormalities (1) · Congenital adrenal hyperplasia due to 21 hydroxylase deficiency (1) · Disorders of Sex Development (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Gonadal Disorders (1) · Hyperplasia (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Pathologic Processes (1) · Steroid Metabolism, Inborn Errors (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Urogenital Diseases (1)
NBI 77860 (1)
United States (1)